VEGFA and ovarian carcinoma: Hyaluronic acid nanoparticles encapsulated with miR-125b specifically target TAMs in the peritoneal cavity of ID8-VEGF ovarian cancer mice and repolarize macrophages to an immune-activating phenotype (54).